Speakers

Soyoung Yi
Republic of Korea, Director General of
Pharmaceutical Performance Assessment
Department of HIRA
Speakers
Soyoung Yi
Republic of Korea, Director General of
Pharmaceutical Performance Assessment
Department of HIRA
Speakers
Soyoung Yi
Republic of Korea, Director General of
Pharmaceutical Performance Assessment
Department of HIRA
Health Insurance Review and Assessment Service(HIRA)
60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. +82-2-1644-2000
Agency Omni Management. Co., Ltd.
(Corporate Registration No. 806-88-01176) 811, Ryuma Tower2, 59-17, Magokjungang-ro, Gangseo-gu, Seoul, Korea / TEL. +82-2-2667-0030
Health Insurance Review and Assessment Service(HIRA)
(26465) 60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. 1644-2000
Agency Omni Management. Co., Ltd.
(Corporate Registration No. 806-88-01176)
811, Ryuma Tower2, 59-17, Magokjungang-ro, Gangseo-gu, Seoul, Korea / TEL. 02-2667-0030
Vandana Ayyar Gupta
UK, Scientific Advisor of NICE
[Experience]
– Scientific Adviser in Data & Analytics of National Institute for Health and Care Excellence, UK
– Development of NICE’s Real World Evidence Framework and Helping to Transform NICE’s Use of Real-world Data across Guidance Products, UK
– the Management of the National Rare Disease Registry of University College London, UK (Duchenne Muscular Dystrophy)
– the Clinical and Research Capacity within the National Health Service, UK
[Education]
– MSc in Research Methods and a PhD in Public Health at Queen Margaret University, UK
Soyoung Yi
Republic of Korea, Director General of Pharmaceutical Performance Assessment Department of HIRA
[Experience]
– Director General of Pharmaceutical Performance Assessment Department of HIRA, Republic of Korea
– Director General of Health Insurance Review and Assessment Research Department of HIRA, Republic of Korea
– Director General of the Korea Pharmaceutical Information Service of HIRA, Republic of Korea (Jul 2021~Dec 2023)
– Director General of the Benefits Information Analysis Department of HIRA, Republic of Korea (Jul 2020~Jun 2021)
– Director General of Research Coordination of HIRA, Republic of Korea (May 2017~Jun 2018)
[Education]
– Doctor of Medicine at Seoul National University Graduate School, Republic of Korea (2004)
– Master of Medicine at Seoul National University Graduate School, Republic of Korea (2001)
– Bachelor of Pharmacy at Chung-Ang University College of Pharmacy, Republic of Korea (1994)
Bor-Sheng Ko
Taiwan, Professor of NTUCC
[Experience]
– Associate Professor and Director of Department of Hematological Oncology of National Taiwan University Cancer Center, Taiwan
– Attending Physician of Department of Internal Medicine of National Taiwan University Hospital, Taiwan
– Director of Tai-Cheng Cell Therapy Center of National Taiwan University, Taiwan
– President of Hematology Society of Taiwan (HST), Taiwan
– Executive Director and Ex-President, Taiwan Society of Pharmaco-economics and Outcome Research (TaSPOR) / International Society of Pharmaco-economics and Outcome Research (ISPOR)-Taiwan Chapter, Taiwan
– President of TaSPOR and ISPOR-Taiwan Chapter, Taiwan (2018~2023)
– President of the Taiwan Society of Blood and Marrow Transplantation (TBMT), Taiwan (2019~2022)
– the position of Secretary-General of the Taiwan Society of Blood and Marrow Transplantation (TBMT), Taiwan (2013~2019)
– Investigator at the National Health Research Institute, Taiwan (2010~2014)
– A Visiting Research Scholar at The University of Texas Health Science Center in Houston and the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center of the University of Texas, USA (2006~2007)
[Education]
– PhD in the Institute of Clinical Medicine at the National Taiwan University College of Medicine, Taiwan (2011)
– Completed his clinical training in Internal Medicine and Hematology/Hematopoietic Stem Cell Transplant (HSCT) fellowship at the National Taiwan University Hospital, Taiwan
– Medical Degree at the National Taiwan University College of Medicine, Taiwan (1995)
Nicole Mittmann
Canada, Vice President of CDA
[Experience]
– Vice President of Canada’s Drug Agency, Canada
– Chief Scientist of Scientific Evidence, Methodologies, and Resources of Canada’s Drug Agency, Canada
– Assistant Professor at the University of Toronto in the Department of Pharmacology & Toxicology, Canada
– Cross-appointed to the Institute for Health Policy, Management and Evaluation, Canada
– Associate scientist at Sunnybrook Health Sciences Center in Toronto, Canada
[Education]
– PhD in Pharmacology at the University of Toronto
– MSc in Pharmacology at the University of Toronto
Jatin K. Dave
USA, Professor of UMASSMED
[Experience]
– Associate Professor of Population and Quantitative Health Sciences of UMass Chan Medical School, USA
– Chief Medical Officer of MassHealth, USA
– Consultant for the Palliative Care Team at Tufts Medical Center and Assistant Clinical Professor of Tufts University School of Medicine, USA
– Chief Medical Officer of New England Quality Care Alliance, USA (Oct 2016~Jun 2020)
– Medical Director of Geriatrics and Senior Care Options at Tufts Health Plan, USA (Mar 2011~Oct 2016)
– Primary Care Physician and Consultant Geriatrician, as well as Director of Education at Brigham and Women’s Hospital, USA (2004~Dec 2016)
[Education]
– Master’s degree in Public Health from the Harvard School of Public Health, USA
– Completed a Fellowship in Geriatric Medicine at Harvard University, USA
– Completed a General Internal Medicine Fellowship at New York University, USA
– Training in Internal Medicine at the University of Illinois College of Medicine, USA
– Bachelor’s degree in Medicine and in Surgery at Gujarat University, India
Claus Møldrup
Denmark, Director of Data Analytics Center of DKMA
[Experience]
– Director of Data Analytics Center of Danish Medicines Agency, Denmark
– CEO and Co-founder of Parazute, Denmark (Jun 2022~Apr 2024)
– CEO and Founder of DrugStars ApS, Denmark (May 2016~Oct 2021)
– Commercial Director and Executive Management of AbbVie, Denmark (Nov 2011~Apr 2021)
– Head of Department of University of Copenhagen, Denmark (2008~2011)
– Visiting Professor of INSEAD, France (Mar 2006~Mar 2008)
– Director of Copenhagen TBWA\Worldwide (Jan 2006~Sep 2011)
– Associated Professor of University of Copenhagen, Denmark (2002~2008)
– Post Doc of University of Copenhagen, Denmark (2002-2002)
[Education]
– Doctor of Philosophy of Social Pharmacy at Copenhagen University, Denmark (1991-2000)
Yoonsoo Park
Republic of Korea, Chair of the Subcommittee for Economic Feasibility Evaluation of HIRA
[Experience]
– Chair of the Subcommittee for Economic Feasibility Evaluation of HIRA, Republic of Korea
– Professor of Infectious Diseases at Yongin Severance Hospital, Republic of Korea
– Chief of Infectious Diseases of National Health Insurance Service Ilsan Hospital, Republic of Korea
[Education]
– Doctor of Medicine at Yonsei University, Republic of Korea
Jungsin Lee
Republic of Korea, Chair of Pharmaceutical Benefits Assessment Committee of HIRA
[Experience]
– Chair of Pharmaceutical Benefits Assessment Committee of HIRA, Republic of Korea
– Emeritus Professor of Ulsan University, Republic of Korea
– President of Asan Medical Center, Republic of Korea
– President of Korean Cancer Association, Republic of Korea
[Education]
– Doctor of Medicine at Kyunghee University Graduate School, Republic of Korea
Neha Kashalikar
USA, Manager of Strategic Pharmacy Contracting of MassHealth
[Experience]
– Manager of Strategic Pharmacy Contracting of MassHealth, USA
– the Role of Pharmacy Program Manager in the Massachusetts Behavioral Health Partnership (MBHP), USA
– Clinical Consultant Pharmacist of Massachusetts Medicaid in UMass Chan Medical School, USA
[Education]
– Completed a Pharmacy Practice Residency at the University of Massachusetts Medical School of Clinical Pharmacy Services, USA
– Doctor of Pharmacy degree at Northeastern University’s School of Pharmacy, USA